Drug Database
ME

metronidazole (Anabact)

✓ Approved

Bioglan Laboratories · 小分子 · 小分子

什么是 metronidazole?

metronidazole 是一种小分子,由Bioglan Laboratories研发。该药已获批,用于治疗相关适应症,给药途径:Topical。

药物档案

商品名Anabact
公司Bioglan Laboratories
药物类别小分子
给药途径Topical
状态Approved

治疗适应症

metronidazole 针对 1 个适应症,涉及 1 个治疗领域。

治疗领域疾病/病症分期
Infections and infestationsSalmonellosis✓ Approved

相关研究文献

PubMedDEN open2026-11-18

Long-standing Chronic Diarrhea Associated With Intestinal Spirochetosis Incidentally Diagnosed in a Rectal Adenoma Specimen Resected by Cold Snare Polypectomy: A Case Report.

Tajika Masahiro M, Takagi Akihiro A, Hori Makoto M, Ito Nobuhito N et al.

Intestinal spirochetosis (IS) is an uncommon condition that is often asymptomatic and detected incidentally but may occasionally present with chronic diarrhea. We report a case of IS incidentally identified in the adjacent non-neoplastic mucosa of a rectal adenoma specimen resected by cold snare polypectomy. We present a case of a man in his 50s who was referred for a positive fecal occult blood test and had a history of chronic diarrhea. Colonoscopy revealed a 5-mm sessile polyp in the upper rectum, which was removed by cold snare polypectomy. Histopathological examination showed a tubular adenoma. In addition, routine hematoxylin and eosin staining revealed a characteristic false brush border on the adjacent non-neoplastic colorectal epithelium, consistent with IS. A detailed medical interview subsequently revealed chronic diarrhea for more than 10 years and prolonged close contact with a pet dog. Treatment with metronidazole (1500 mg/day for 10 days) resulted in resolution of the diarrhea. This case highlights the importance of careful histopathological examination and detailed history-taking in patients with IS.

PMID 43048568
阅读全文 →
PubMedEnvironmental science & technology2026-11-17

Ammonia Triggers Interfacial Breakpoint Chlorination to Enhance Micropollutant Degradation and Reshapes Chlorinated Byproduct Formation during Electrochlorination.

Hua Zhechao Z, Zhu Jierui J, He Dequan D, Zeng Zhiyuan Z et al.

Electrochlorination is a promising technology for micropollutant degradation in decentralized water treatment. However, ammonia can alter chlorine chemistry. This study investigates the effect of ammonia on micropollutant degradation and chlorinated byproduct formation during electrochlorination using the RuO2/IrO2-Ti anode. Compared to electrochlorination at 10 mM chloride without ammonia, the presence of 1 mM ammonia increased the degradation rate constants of metronidazole and carbamazepine by 2.7- and 4.5-fold, respectively. This enhancement is consistent with interfacial breakpoint chlorination, defined as preferential chlorine-ammonia conversion within an anode-adjacent, chlorine-rich aqueous diffusion layer before complete bulk mixing. During electrochlorination with ammonia, dissolved HO• contributed to micropollutant degradation. Electron paramagnetic resonance provided qualitative evidence of HO• formation, whereas nitrobenzene was used as a probe to quantify its steady-state concentration. The ammonia-induced steady-state HO• concentration reached 2.4 × 10-13 M at 1 mM ammonia, whereas the HO• contribution was negligible without ammonia. Meanwhile, 1-5 mM ammonia reduced the total yields of chlorinated byproducts by only 25-31% during electrochlorination. The limited suppression is consistent with concurrent competition between ammonia and dissolved organic matter for locally generated chlorine within the anode-adjacent region. These findings identify near-anode chlorine-ammonia conversion as a route to reactive-species formation and micropollutant degradation, while showing that chlorinated byproducts remain a concern in ammonia-containing electrochlorination systems.

PMID 43043266
阅读全文 →
PubMedCell communication and signaling : CCS2026-11-17

Design and characterization of a LuxS/AI-2 pathway-informed scorpion venom-derived hybrid peptide IFG-22 for selective inhibition of Gardnerella vaginalis biofilms in bacterial vaginosis.

Xu Wenxin W, Zhang Zhiren Z, Xu Qingbo Q, Wang Dandan D et al.

Bacterial vaginosis (BV) is a common vaginal dysbiosis characterized by Gardnerella vaginalis overgrowth, biofilm persistence, inflammation, and disruption of Lactobacillus-dominated microbiota. Conventional antibiotics such as metronidazole are limited by recurrence, incomplete biofilm clearance, and potential disturbance of beneficial commensals. Here, we designed and characterized IFG-22, a LuxS/AI-2 pathway-informed scorpion venom-derived hybrid antimicrobial peptide, to preferentially target G. vaginalis biofilms while preserving vaginal microbial homeostasis. IFG-22 was generated by integrating a LuxS-guided recognition motif with a membrane-active antimicrobial fragment and was optimized through molecular docking and physicochemical screening. IFG-22 showed potent anti-Gardnerella activity, with a minimum inhibitory concentration of 1.2 µg/mL, rapid bactericidal kinetics, and marked inhibition of biofilm formation and persistence. Mechanistic assays indicated that IFG-22 attenuated AI-2-associated signaling output, showed partially DPD/AI-2-rescuable biofilm suppression, selectively interacted with G. vaginalis biofilm lipid components, and induced bacterial membrane disruption. These findings support a combined mechanism in which membrane disruption drives rapid killing, while AI-2-associated signaling attenuation contributes to anti-biofilm activity. IFG-22 displayed weaker activity against representative vaginal commensals than against G. vaginalis and showed preliminary compatibility with vaginal epithelial cells within the effective antimicrobial concentration range. In a murine BV model, IFG-22 reduced G. vaginalis expansion, promoted restoration toward a Lactobacillus-dominated microbiota, and downregulated inflammatory mediator expression in vaginal tissues. IFG-22 also retained substantial peptide integrity and anti-Gardnerella activity under simulated vaginal microenvironmental conditions. Collectively, IFG-22 represents a promising membrane-active and microbiota-sparing peptide candidate for local BV therapy.

PMID 43040356
阅读全文 →
PubMedInfection and drug resistance2026-11-17

Antimicrobial Resistance and Genomic Characteristics of Helicobacter pylori in Peptic Ulcer Disease: A Five-Case Series.

Fang Yunhui Y, Wang Kun K

Peptic ulcer disease is a well-established clinical manifestation of Helicobacter pylori infection. Antimicrobial resistance can compromise eradication, particularly after prior treatment. We describe a small surveillance-based case series integrating clinical history, phenotypic antimicrobial susceptibility, and genomic findings; the series was not designed to estimate population-level resistance patterns. Five patients with endoscopically documented gastric and/or duodenal ulcer and culture-confirmed H. pylori infection were identified during routine clinical microbiological surveillance from March 2023 to April 2024. Clinical data, Minimum Inhibitory Concentration (MIC)-based antimicrobial susceptibility, selected variants in resistance-related loci, virulence-associated genes, genome assembly characteristics, and a core-genome alignment-based comparative overview were analyzed descriptively; no inferential statistical testing was performed. The five patients were 25-51 years old and had endoscopically documented gastric and/or duodenal ulcers; concomitant gastritis or mucosal erosion was recorded separately. Four patients had documented prior eradication exposure, whereas treatment history was incomplete for one. All five isolates were resistant to clarithromycin and metronidazole and susceptible to levofloxacin, tetracycline, and rifampicin; two were also resistant to amoxicillin and met the study definition of multidrug resistance. All isolates carried 23S rRNA substitutions including the established clarithromycin resistance-associated A2147G substitution, whereas no gyrA resistance-associated substitution was detected. cytotoxin-associated gene A (cagA) was detected in all five isolates. Draft genome sizes ranged from 1.55 to 1.65 Mb, with GC contents of 38.54-38.82%. In the descriptive core-genome alignment-based tree, isolates 207, 318, and 221 formed a relatively close branch, whereas isolates 171 and 317 were more distinct. These genomic relationships were not interpreted as evidence of epidemiological clustering. This descriptive five-case series illustrates heterogeneous case-level antimicrobial susceptibility and genomic profiles in ulcer-associated H. pylori infection. The observations are not population-level resistance estimates, but they support the clinical value of culture-based susceptibility testing and/or validated molecular resistance detection for individualized management, particularly after prior eradication treatment.

PMID 43041343
阅读全文 →
PubMedRevista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)2026-11-16

First report of flare-up phenomenon during bismuth subcitrate provocation test.

García Jimena Laiseca JL, Mazuecos Juan María Beitia JMB, Violán Victoria Villalobos VV, Trujillo María Jesús Trujillo MJT et al.

Immediate hypersensitivity to bismuth subcitrate is rare, and established diagnostic protocols are scarce. A 28-year-old female patient with no history of drug allergies presented with malaise, nausea, pruritus, urticaria on the arms, and eyelid edema after taking a dose of Pylera® (bismuth/metronidazole/tetracycline) and omeprazole; symptoms resolved after three days following treatment with antihistamines and corticosteroids. Two months later, skin tests (prick and intradermal tests) for metronidazole, omeprazole, and doxycycline were negative. Tests with Pylera® and bismuth subcitrate caused erythema, raising suspicion of an irritant reaction. Tests with the excipient polyethylene glycol were also negative. A graded oral provocation test with bismuth subcitrate was performed; 30 minutes after the final dose, lesions appeared in the axillae and groin, accompanied by a reactivation reaction (flare-up) at the site of the previous bismuth skin tests. The diagnosis of allergic hypersensitivity to bismuth subcitrate was confirmed, while the other components and the suspicion of an irritant reaction were ruled out. Recognizing immediate hypersensitivity syndrome to bismuth subcitrate provides additional evidence for establishing drug causality during allergological evaluation and assists clinicians in interpreting similar findings during the investigation of drug hypersensitivity. Based on the foregoing, further studies are needed to determine the clinical relevance of immediate hypersensitivity syndrome to bismuth subcitrate.

PMID 43037221
阅读全文 →
PubMedCureus2026-11-16

Meningoencephalitis Caused by Porphyromonas gingivalis: A Case Report and Literature Review.

Blazevic Mateo M, Kamm Christian P CP, Gyurkó Dávid M DM, Bertschy Sonja S et al.

Anaerobic bacteria are a rare cause of adult bacterial meningitis. We report the case of a 48-year-old man who presented with fever, confusion, headache, and word-finding difficulty approximately two weeks after molar extraction performed in the setting of periodontal disease. Cerebrospinal fluid (CSF) analysis showed findings consistent with bacterial meningitis, while routine cultures remained negative. Additional broad-range eubacterial polymerase chain reaction (PCR) of the initial CSF sample detected Porphyromonas gingivalis DNA, leading to targeted antimicrobial therapy with ceftriaxone and metronidazole. Periodontal source control was achieved through extraction of multiple molars. The patient showed gradual neurological improvement but required prolonged inpatient rehabilitation due to persistent dizziness, ultimately achieving independent ambulation and complete resolution of headaches. This case highlights the importance of considering a possible odontogenic source in patients presenting with meningitis following recent dental procedures. Molecular diagnostics may aid pathogen identification when CSF findings suggest bacterial infection despite negative cultures. In this patient, source control and antimicrobial therapy were followed by a favorable neurological outcome.

PMID 43036615
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多metronidazole